Literature DB >> 12880294

Visualization of insulin-loaded nanocapsules: in vitro and in vivo studies after oral administration to rats.

Huguette Pinto-Alphandary1, Malam Aboubakar, Danielle Jaillard, Patrick Couvreur, Christine Vauthier.   

Abstract

PURPOSE: Biodegradable poly(isobutylcyanoacrylate) nanocapsules have been recognized as a promising carrier for oral administration of peptides and proteins. In the present study, we investigate the fate of insulin-loaded nanocapsules by fluorescence and transmission electron microscopy (TEM) after intragastric force-feeding to rats.
METHODS: Insulin-, Texas-red-labeled insulin, or gold-labeled insulin-loaded nanocapsules were first characterized. Rats received a single dose of nanocapsules (diameter 60-300 nm, 57 IU insulin/kg) by intragastric force-feeding. After 90 min, ileum was isolated and prepared for fluorescence and transmission electron microscopy.
RESULTS: Nanocapsules were observed on both sides of the gut epithelium and in blood capillaries. In M-cell-free epithelium, apparently intact nanocapsules could be seen in the underlying tissue, suggesting they could cross the epithelium and carry the encapsulated peptide. In M-cell-containing epithelium, nanocapsules appeared degraded in the vicinity of macrophages. It is noteworthy that intestinal absorption of nanocapsules was observed without artifacts forcing the nanocapsules to stay in the gut.
CONCLUSIONS: Based on TEM observations, this study shows the intestinal absorption of biodegradable nanocapsules leading to the transport of insulin across the epithelium mucosa. The fate of the nanocapsules appeared different depending on the presence or the absence of M cells in the intestinal epithelium.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12880294     DOI: 10.1023/a:1024470508758

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

Review 1.  The development of delivery agents that facilitate the oral absorption of macromolecular drugs.

Authors:  A Leone-Bay; D R Paton; J J Weidner
Journal:  Med Res Rev       Date:  2000-03       Impact factor: 12.944

2.  Evaluation of nano- and microparticle uptake by the gastrointestinal tract.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-12-01       Impact factor: 15.470

Review 3.  Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics.

Authors:  N Hussain; V Jaitley; A T Florence
Journal:  Adv Drug Deliv Rev       Date:  2001-08-23       Impact factor: 15.470

Review 4.  The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual.

Authors:  A T Florence
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

5.  Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles.

Authors:  A M Hillery; P U Jani; A T Florence
Journal:  J Drug Target       Date:  1994       Impact factor: 5.121

6.  Absorption and efficiency of insulin after oral administration of insulin-loaded nanocapsules in diabetic rats.

Authors:  F Cournarie; D Auchere; D Chevenne; B Lacour; M Seiller; C Vauthier
Journal:  Int J Pharm       Date:  2002-08-21       Impact factor: 5.875

7.  Degradation of poly (isobutyl cyanoacrylate) nanoparticles.

Authors:  V Lenaerts; P Couvreur; D Christiaens-Leyh; E Joiris; M Roland; B Rollman; P Speiser
Journal:  Biomaterials       Date:  1984-03       Impact factor: 12.479

8.  Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats.

Authors:  P J Lowe; C S Temple
Journal:  J Pharm Pharmacol       Date:  1994-07       Impact factor: 3.765

9.  New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier.

Authors:  C Damgé; C Michel; M Aprahamian; P Couvreur
Journal:  Diabetes       Date:  1988-02       Impact factor: 9.461

10.  Intracellular visualization of ampicillin-loaded nanoparticles in peritoneal macrophages infected in vitro with Salmonella typhimurium.

Authors:  H Pinto-Alphandary; O Balland; M Laurent; A Andremont; F Puisieux; P Couvreur
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

View more
  8 in total

Review 1.  Past, present, and future technologies for oral delivery of therapeutic proteins.

Authors:  Rajesh Singh; Shailesh Singh; James W Lillard
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

Review 2.  Nanocarriers' entry into the cell: relevance to drug delivery.

Authors:  Hervé Hillaireau; Patrick Couvreur
Journal:  Cell Mol Life Sci       Date:  2009-06-05       Impact factor: 9.261

Review 3.  Methods for the preparation and manufacture of polymeric nanoparticles.

Authors:  Christine Vauthier; Kawthar Bouchemal
Journal:  Pharm Res       Date:  2008-12-24       Impact factor: 4.200

4.  Alginate/chitosan nanoparticles are effective for oral insulin delivery.

Authors:  B Sarmento; A Ribeiro; F Veiga; P Sampaio; R Neufeld; D Ferreira
Journal:  Pharm Res       Date:  2007-06-19       Impact factor: 4.200

5.  Nanocapsules: the weapons for novel drug delivery systems.

Authors:  Pavankumar Kothamasu; Hemanth Kanumur; Niranjan Ravur; Chiranjeevi Maddu; Radhika Parasuramrajam; Sivakumar Thangavel
Journal:  Bioimpacts       Date:  2012-04-05

6.  Alginate Microencapsulation for Oral Immunisation of Finfish: Release Characteristics, Ex Vivo Intestinal Uptake and In Vivo Administration in Atlantic Salmon, Salmo salar L.

Authors:  Bikramjit Ghosh; Barbara F Nowak; Andrew R Bridle
Journal:  Mar Biotechnol (NY)       Date:  2015-09-26       Impact factor: 3.619

Review 7.  Nanotechnology: intelligent design to treat complex disease.

Authors:  Patrick Couvreur; Christine Vauthier
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.580

8.  Understanding the translocation mechanism of PLGA nanoparticles across round window membrane into the inner ear: a guideline for inner ear drug delivery based on nanomedicine.

Authors:  Liping Zhang; Yuan Xu; Wenjuan Cao; Shibao Xie; Lu Wen; Gang Chen
Journal:  Int J Nanomedicine       Date:  2018-01-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.